Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
Abstract Background and aims Malignant melanoma is an aggressive tumor sensitive for immunotherapy such as checkpoint blockade antibodies. Still, most patients with late stage disease do not respond, and the side effects can be severe. Stimulation of the CD40 pathway to initiate anti-tumor immunity...
Main Authors: | A. Schiza, J. Wenthe, S. Mangsbo, E. Eriksson, Anders Nilsson, T. H. Tötterman, A. Loskog, G. Ullenhag |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-017-1182-z |
Similar Items
-
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up
by: Sara Saellstrom, et al.
Published: (2021-07-01) -
Experimental treatment of patients with disseminated malignant melanoma
by: Schiza, Aglaia
Published: (2017) -
Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01) -
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
by: Jessica C. Hassel, et al.
Published: (2017-09-01) -
Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
by: A. Yu. Morenkova, et al.
Published: (2021-05-01)